Through the 90-day period concluding February 19, 2026, Indaptus Therapeutics's top three insider stakeholders include Co Chief Executive Officer Jeffrey A Meckler (229.93K shares), Cso And Director Michael James Newman (149.94K shares), Chief Operating Officer Walt Addison Linscott (54.43K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Michael James Newman | Cso And Director | 149,938 | 29 Dec, 2025 |
| Glen R. Anderson | 42,509 | 16 Aug, 2023 | |
| Jeffrey A Meckler | Co Chief Executive Officer | 229,929 | 29 Dec, 2025 |
| Walt Addison Linscott | Chief Operating Officer | 54,426 | 29 Dec, 2025 |
| Nir Sassi | Chief Financial Officer | 26,758 | 29 Dec, 2025 |
| Avraham Ben-Tzvi | 25,100 | 22 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Jan, 2026 | Avraham Ben-Tzvi | Common Stock | A | 25,000 | $0.00 | 25,100 | D | A |
| 22 Dec, 2025 | Jeffrey A Meckler | Common Stock | A | 216,617 | $2.03 | 229,929 | D | A |
| 22 Dec, 2025 | Walt Addison Linscott | Common Stock | A | 54,421 | $2.03 | 54,426 | D | A |
| 22 Dec, 2025 | Nir Sassi | Common Stock | A | 26,758 | $2.03 | 26,758 | D | A |
| 22 Dec, 2025 | Michael James Newman | Common Stock | A | 52,204 | $2.03 | 101,074 | D | A |
| 27 Jul, 2025 | Jeffrey A Meckler | Common Stock | A | 6,068 | $8.30 | 13,312 | D | A |
| 25 Nov, 2024 | Jeffrey A Meckler | Common stock | A | 42,553 | $1.18 | 7,244 | D | A |
| 08 Aug, 2024 | Jeffrey A Meckler | Common stock | A | 84,932 | $1.82 | 5,725 | D | A |
| 14 Aug, 2023 | Glen R. Anderson | Common Stock | A | 23,934 | $2.34 | 42,509 | I | P |
| 14 Aug, 2023 | Glen R. Anderson | - | - | 42,509 | I | |||
| 11 Aug, 2023 | Glen R. Anderson | - | - | 41,655 | I | |||
| 11 Aug, 2023 | Glen R. Anderson | Common Stock | A | 35,064 | $2.12 | 41,655 | I | P |
| 10 Aug, 2023 | Glen R. Anderson | Common Stock | A | 44,354 | $1.94 | 40,402 | I | P |
| 10 Aug, 2023 | Glen R. Anderson | - | - | 40,402 | I | |||
| 21 Nov, 2022 | Jeffrey A Meckler | Common stock | A | 9,600 | $1.90 | 2,692 | D | P |
| 21 Nov, 2022 | Jeffrey A Meckler | - | - | 2,692 | D | |||
| 18 Nov, 2022 | Jeffrey A Meckler | Common stock | A | 400 | $1.76 | 2,349 | D | P |
| 18 Nov, 2022 | Jeffrey A Meckler | - | - | 2,349 | D | |||
| 08 Sep, 2022 | Jeffrey A Meckler | Common stock | A | 10,308 | $2.80 | 2,335 | D | P |
| 07 Sep, 2022 | Jeffrey A Meckler | Common stock | A | 8,632 | $2.57 | 1,966 | D | P |